Fulvestrant in postmenopausal women with locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy: a guide Katherine A. Lyseng-Williamson Adis Drug Q&A 19 August 2015 Pages: 323 - 328
Nintedanib in idiopathic pulmonary fibrosis: a guide to its use Gillian M. Keating Adis Drug Q&A 27 August 2015 Pages: 329 - 333
Liraglutide in obesity: a guide to its use in the EU Lesley J. Scott Adis Drug Q&A 26 August 2015 Pages: 334 - 340
Central precocious puberty: consider early treatment with gonadotropin-releasing hormone analogues to preserve maximum height Adis Medical Writers Disease Management 18 August 2015 Pages: 341 - 344
Consider mineralocorticoid receptor antagonists as add-on therapy in treatment-resistant hypertension Adis Medical Writers Disease Management 21 July 2015 Pages: 345 - 349
Drug interactions are an important issue in type 2 diabetes Adis Medical Writers Drug Reactions and Interactions 22 July 2015 Pages: 350 - 354
First reports of adverse drug reactions in recent weeks Drug Reactions and Interactions 01 September 2015 Pages: 355 - 357
Drug utilization pattern of NSAIDs assessed with the anatomical therapeutic chemical classification/defined daily dose system in an orthopedic department Nidhi S. PatelRima B. ShahJatin G. Buch Original Research Article 07 August 2015 Pages: 358 - 364